GlassScriptPhysician profile
Veronica H Flood
NPI 1205846466
$27,647.58
in general payments reported to CMS, 2019-2025
6 companies · $10K in 2025
The $10K reported for 2025 was more than what 85% of Pediatric Hematology-Oncology providers received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,161 · 2023: $2,918 · 2024: $10K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Consulting Fee: $7,977 · Honoraria: $5,000 · Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,200.73 |
| Consulting Fee | $7,977.00 |
| Honoraria | $5,000.00 |
| Food and Beverage | $309.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $19,337.13 | 2022-2025 | Wilate - Von Willebrand Factor/Coagulation Factor Viii Complex (Human) |
| Takeda Pharmaceuticals U.S.A., INC. | $6,278.66 | 2023-2025 | Adynovate, Advate |
| Novo Nordisk Health Care Ag | $1,965.00 | 2025 | |
| Csl Behring | $24.15 | 2022 | |
| Pfizer INC. | $21.52 | 2025 | |
| Sobi, INC | $21.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Flood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.